Skip to main content

Cencora Inc(COR-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low325.90
Day High333.34
Open:327.23
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Cencora Inc

Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB) and Cencora (COR)
Tipranks
Wells Fargo Keeps Their Buy Rating on Cencora (COR)
Tipranks
Barclays Sticks to Their Buy Rating for Cencora (COR)
Tipranks
Cencora CFO Retirement Announced, Financial Guidance Reaffirmed
StockStory
1 Healthcare Stock with Exciting Potential and 2 We Ignore
SOLV
Zacks Investment Research
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
Zacks Investment Research
Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26?
Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26?
Tipranks
Cencora Shareholders Reaffirm Board, Pay and Auditor Oversight
Tipranks
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Cencora (COR) and Caribou Biosciences (CRBU)
Motley Fool
Investment Firm Bets Big on ESAB's Welding and Cutting Technology
Tipranks
Cencora Restructures Animal Health Business in Covetrus Merger
Tipranks
Cencora Prices $3 Billion Senior Notes Offering
StockStory
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know
COR
Tipranks
Cencora Issues $3 Billion in Senior Unsecured Notes
StockStory
1 Momentum Stock with Impressive Fundamentals and 2 We Question
COR
Tipranks
Cencora Updates Segment Reporting Following Strategic Business Review
StockStory
5 Revealing Analyst Questions From Cencora’s Q4 Earnings Call
COR
Zacks Investment Research
Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic
Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic
StockStory
Cencora (COR) Stock Trades Up, Here Is Why
COR
Tipranks
Cencora Completes OneOncology Acquisition, Lifts Guidance
StockStory
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts
COR
Motley Fool
Cencora (COR) Q1 2026 Earnings Call Transcript
StockStory
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates
COR
StockStory
Cencora (COR) Reports Earnings Tomorrow: What To Expect
COR
Tipranks
Cencora Expands Board with Appointment of New Director
Tipranks
Cencora Expands Credit Facilities to Finance OneOncology Deal
Tipranks
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Centene (CNC) and Cencora (COR)
Tipranks
Evercore ISI Sticks to Their Buy Rating for Cencora (COR)
Zacks Investment Research
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds
Zacks Investment Research
Here's Why You Should Retain Cencora Stock in Your Portfolio Now
Here's Why You Should Retain Cencora Stock in Your Portfolio Now
StockStory
3 Healthcare Stocks with Exciting Potential
ABBV
Zacks Investment Research
McKesson Builds Earnings Momentum on Specialty and Automation
McKesson Builds Earnings Momentum on Specialty and Automation

Profile

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.